Development of effective, accessible rapid diagnostics and biosensor screening tests for early detection and the potential for better treatment outcomes and improved disease management.
Our Diagnostic Products
COVID-19 PCR Diagnostic Kit
Launching in 2021, our rapid COVID-19 test is designed to provide results in less than 25 minutes. Compatible with both nasal and oral samples, our test can provide a more comfortable and less invasive point-of-care experience.
H1N1 (Swine Flu) and H5N1 (Avian Flu) Oral Biosensors
This series of biosensors planned for launch in late 2021 will help with early detection of highly pathogenic influenza A strains. They are administered via oral dissolvable films, releasing a bitter compound for positive results.